NRC Health has been selected by UCHealth to be its partner in building Human Understanding through personalized healthcare solutions and data-driven i...
Under the terms of the agreement, Aligos and Amoytop will collaborate on the research and development of oligonucleotide compounds for the treatment of liv...
Once issued, the patent maturing from this allowed patent application is expected to expire no earlier than February 2039. The allowed claims cover MN...
The co-development of healthPrecision's Medical Brain artificial intelligence (AI) platform at BayCare will be the first time the technology has been a...
Phase II dose-finding trial met primary endpoint after 46 weeks of treatment, representing an important advancement of Boehringer Ingelheim’s cardi...
Collaboration will leverage Bicycle Therapeutic’s synthetic peptides for the discovery and development of multiple targeted radioconjugates of the ...
Recently completed first cohort in Phase 1b/2 trial evaluating Annamycin in combination with cytarabine (Ara-C) for the treatment of acute myeloid leukemia...
Increasing localized access can provide faster results for patients while potentially improving patient outcomes Agreement aims to enable greater access...
Marcus Kuhnert will step down as Chief Financial Officer and Member of the Executive Board after a successful nine-year tenure Helene von Roeder appoint...
Exothera Nucleic Acids, the world's first nucleic acid CRDMO to provide continuous RNA manufacturing services from early discovery up to commercial cGMP, a...
Transformation aimed at revolutionizing next generation scientific breakthroughs that solve the world’s greatest health challenges Tru...
Pharma service provider further expands offerings for clinical development and manufacturing Already 14 customer fills completed in the first quarter of...
Details of the events are as follows: Event: Event: BIO International ConventionDate: June 5-8, 2023Registration: https://www.bio.org/events/bio-internati...
Under the terms of the agreement, Acorda will receive an up-front payment of $2.5 million, a near term milestone payment of up to $6 million, $3 million up...
© 2024 Biopharma Boardroom. All Rights Reserved.
